High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy

Author(s):

Simon J. Hume, Danny K. Wong, Man Fung Yuen, Kathy Jackson, Sara Bonanzinga, Sara Vogrin, Samuel A.L. Hall, Gareth S. Burns, Paul V. Desmond, Vijaya Sundararajan, Dilip Ratnam, Miriam T. Levy, John S. Lubel, Amanda J. Nicoll, Simone I. Strasser, William Sievert, Meng C. Ngu, Marie Sinclair, Christopher Meredith, Gail Matthews, Peter A. Revill, Margaret Littlejohn, Scott Bowden, Kumar Visvanathan, Jacinta A. Holmes, Alexander J. Thompson

Details:

Liver International, Volume 44, Issue 10, 2024-10-01

Article Link: Click here

Affiliations:

• University of Melbourne
• The University of Hong Kong
• Royal Prince Alfred Hospital
• St. Vincent's Hospital Melbourne
• Austin Health
• St. Vincent's Hospital Sydney
• Monash Health
• Concord Repatriation General Hospital
• The Peter Doherty Institute for Infection and Immunity
• Western Health
• Eastern Health
• Alfred Health
• Liverpool Hospital
• Bankstown-Lindcombe Hospital